Aarhus Universitets segl

Left atrial appendage occlusion

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review


  • David R Holmes, Mayo Clinic Rochester, MN
  • ,
  • Kasper Korsholm
  • Josep Rodés-Cabau, Université Laval
  • ,
  • Jacqueline Saw, University of British Columbia
  • ,
  • Sergio Berti, Paediatric Cardiology Unit, Niguarda Hospital, Milan, Italy.
  • ,
  • Mohamad A Alkhouli, Mayo Clinic Rochester, MN

Prevention of stroke represents a goal of primary importance in health systems due to its associated morbidity and mortality. As several patient groups with increased stroke rates have been identified, multiple approaches have been developed and implemented: oral anticoagulation (OAC) for patients with atrial fibrillation, surgical and percutaneous revascularisation in patients with carotid disease, device closure for patients with patent foramen ovale, and now, left atrial appendage occlusion (LAAO) for selected patients with non-valvular atrial fibrillation (NVAF). The latter group of patients are the focus of this review which evaluates the pathophysiology, selection of patients, procedural performance, outcomes of treatment both during and post-procedure, adjunctive therapy, complications, and longer-term outcomes.

TidsskriftEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Sider (fra-til)e1038-e1065
StatusUdgivet - feb. 2023

Se relationer på Aarhus Universitet Citationsformater

ID: 340325436